Abstract:Endolysins, the cell wall lytic enzymes encoded by bacteriophages to release the phage progeny, are among the top alternatives to fight against multiresistant pathogenic bacteria; one of the current biggest challenges to global health. Their narrow range of susceptible bacteria relies, primarily, on targeting specific cell-wall receptors through specialized modules. The cell wall-binding domain of Cpl-7 endolysin, made of three CW_7 repeats, accounts for its extended-range of substrates. Using as model system … Show more
“…Catalytic domains are responsible for cleavage of peptidoglycan bonds within the cellwall and can be classified into four groups: N-acetylglucosaminidases, N-acetylmuramoyl-Lalanine amidases, N-acetylmuramidases (lysozymes), and endopeptidases [18][19][20]. In contrast, CBDs display much greater variety and distinguish discrete epitopes present within the host cell-wall, typically carbohydrates or teichoic acids, thus giving rise to species-specific or strainspecific activity of a particular endolysin [21,22]. The modular structure of lysins makes it possible to design bioengineered endolysins that have desired properties, such as higher activity, or broader killing spectrum.…”
Using bacteriophage-derived endolysins as an alternative strategy for fighting drug-resistant bacteria has recently been garnering renewed interest. However, their application is still hindered by their narrow spectra of activity. In our previous work, we demonstrated that the endolysin LysIME-EF1 possesses efficient bactericidal activity against multiple strains of Enterococcus faecalis (E. faecalis). Herein, we observed an 8 kDa fragment and hypothesized that it contributes to LysIME-EF1 lytic activity. To examine our hypothesis, we determined the structure of LysIME-EF1 at 1.75 Å resolution. LysIME-EF1 exhibits a unique architecture in which one full-length LysIME-EF1 forms a tetramer with three additional Cterminal cell-wall binding domains (CBDs) that correspond to the abovementioned 8 kDa fragment. Furthermore, we identified an internal ribosomal binding site (RBS) and alternative start codon within LysIME-EF1 gene, which are demonstrated to be responsible for the translation of the truncated CBD. To elucidate the molecular mechanism for the lytic activity of LysIME-EF1, we combined mutagenesis, lytic activity assays and in vivo animal infection experiments. The results confirmed that the additional LysIME-EF1 CBDs are important for LysIME-EF1 architecture and its lytic activity. To our knowledge, this is the first determined structure of multimeric endolysin encoded by a single gene in E. faecalis phages. As such, it may provide valuable insights into designing potent endolysins against the opportunistic pathogen E. faecalis.
“…Catalytic domains are responsible for cleavage of peptidoglycan bonds within the cellwall and can be classified into four groups: N-acetylglucosaminidases, N-acetylmuramoyl-Lalanine amidases, N-acetylmuramidases (lysozymes), and endopeptidases [18][19][20]. In contrast, CBDs display much greater variety and distinguish discrete epitopes present within the host cell-wall, typically carbohydrates or teichoic acids, thus giving rise to species-specific or strainspecific activity of a particular endolysin [21,22]. The modular structure of lysins makes it possible to design bioengineered endolysins that have desired properties, such as higher activity, or broader killing spectrum.…”
Using bacteriophage-derived endolysins as an alternative strategy for fighting drug-resistant bacteria has recently been garnering renewed interest. However, their application is still hindered by their narrow spectra of activity. In our previous work, we demonstrated that the endolysin LysIME-EF1 possesses efficient bactericidal activity against multiple strains of Enterococcus faecalis (E. faecalis). Herein, we observed an 8 kDa fragment and hypothesized that it contributes to LysIME-EF1 lytic activity. To examine our hypothesis, we determined the structure of LysIME-EF1 at 1.75 Å resolution. LysIME-EF1 exhibits a unique architecture in which one full-length LysIME-EF1 forms a tetramer with three additional Cterminal cell-wall binding domains (CBDs) that correspond to the abovementioned 8 kDa fragment. Furthermore, we identified an internal ribosomal binding site (RBS) and alternative start codon within LysIME-EF1 gene, which are demonstrated to be responsible for the translation of the truncated CBD. To elucidate the molecular mechanism for the lytic activity of LysIME-EF1, we combined mutagenesis, lytic activity assays and in vivo animal infection experiments. The results confirmed that the additional LysIME-EF1 CBDs are important for LysIME-EF1 architecture and its lytic activity. To our knowledge, this is the first determined structure of multimeric endolysin encoded by a single gene in E. faecalis phages. As such, it may provide valuable insights into designing potent endolysins against the opportunistic pathogen E. faecalis.
“…CBDs composed of a three‐helix bundle is present in both Gram‐positive and modular Gram‐negative phage endolysins (Table ). The Gram‐positive targeting example, Cpl‐7, uses three repeats of the three helix bundle CW_7 fold to bind to N ‐acetyl‐ d ‐glucosaminyl‐(β1,4)‐ N ‐acetylmuramyl‐ l ‐alanyl‐ d ‐isoglutamine in PG (Bustamante et al ., ) (Fig. C).…”
Section: Structural Repeats Are Common In the Cbdsmentioning
confidence: 86%
“…Computational docking combined with saturation‐transfer difference nuclear magnetic resonance spectroscopy suggest that N ‐acetyl‐ d ‐glucosaminyl‐(β1,4)‐ N ‐acetylmuramyl‐ l ‐alanyl‐ d ‐isoglutamine binds in a shallow groove located between the two last helices of the bundle and the first one at the bottom (Bustamante et al ., ). The interaction is mediated by residues that are conserved in the CW_7 family (Bustamante et al ., ), suggesting other CW_7 domains may bind similar target ligands. The S. agalactiae phage endolysin, λSA2 possesses two CW_7 repeats in an unusual central position between an endopeptidase (N‐terminal) and a glucosaminidase (C‐terminal) domain (Pritchard et al ., ).…”
Section: Structural Repeats Are Common In the Cbdsmentioning
Bacteriophage-encoded endolysins can recognize and bind specific bacteria, and act to cleave the glycosidic and/or amide bonds in the peptidoglycan (PG) bacterial cell wall. Cleavage of the cell wall generally results in the death of the bacteria. Their utility as bacteriolytic agents could be exploited for human and veterinary medicines as well as various biotechnological applications. As interest grows in the commercial uses of these proteins, there has been much effort to successfully employ rational design and engineering to produce endolysins with bespoke properties. In this review, we interrogate the current structural data and identify structural features that would be of benefit to engineering the activity and specificity of phage endolysins. We show that the growing body of structural data can be used to predict catalytic residues and mechanism of action from sequences of hypothetical endolysins, and probe the importance of secondary structure repeats in bacterial cell wall-binding domains.
“…An example is the study of the recognition of the bacterial peptidoglycan by the cell wall-binding domain of the endolysin Cpl-7, which is encoded by the pneumococcal Cp-7 bacteriophage (Bustamante et al, 2017). Cpl-7 is composed of a catalytic domain with muramidase activity and a cell wall-binding domain (C-Cpl-7) made up of three CW_7 repeats.…”
Section: Bacteria Microarrays For Examining Bacterial Surface Glycansmentioning
Bacterial surfaces are decorated with distinct carbohydrate structures that may substantially differ among species and strains. These structures can be recognized by a variety of glycan-binding proteins, playing an important role in the bacteria cross-talk with the host and invading bacteriophages, and also in the formation of bacterial microcolonies and biofilms. In recent years, different microarray approaches for exploring bacterial surface glycans and their recognition by proteins have been developed. A main advantage of the microarray format is the inherent miniaturization of the method, which allows sensitive and high-throughput analyses with very small amounts of sample. Antibody and lectin microarrays have been used for examining bacterial glycosignatures, enabling bacteria identification and differentiation among strains. In addition, microarrays incorporating bacterial carbohydrate structures have served to evaluate their recognition by diverse host/phage/bacterial glycan-binding proteins, such as lectins, effectors of the immune system, or bacterial and phagic cell wall lysins, and to identify antigenic determinants for vaccine development. The list of samples printed in the arrays includes polysaccharides, lipopoly/lipooligosaccharides, (lipo)teichoic acids, and peptidoglycans, as well as sequence-defined oligosaccharide fragments. Moreover, microarrays of cell wall fragments and entire bacterial cells have been developed, which also allow to study bacterial glycosylation patterns. In this review, examples of the different microarray platforms and applications are presented with a view to give the current state-of-the-art and future prospects in this field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.